Innate Pharma S.A Cash Flow Statement 2018-2024 | IPHA

Fifteen years of historical annual cash flow statements for Innate Pharma S.A (IPHA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-8.19$-61.22$-62.48$-73.09$-23.25$3.60
$5.51$47.84$5.44$64.88$18.51$8.74
$2.18$6.37$-0.43$5.28$-1.22$4.86
$7.69$54.21$5.01$70.16$17.29$13.60
$-14.79$-4.43$0$0$0$0
$0$0$0$0$0$0
$-4.21$-8.07$0$0$0$0
$-15.73$-0.67$-11.69$-56.21$45.07$-55.62
$-34.73$-13.17$-11.69$-56.21$45.07$-55.62
$-35.24$-20.18$-69.16$-59.13$39.11$-38.42
$-0.22$-0.56$-1.09$-1.03$-1.42$-1.03
$-2.16$-0.62$-0.47$-11.85$-71.83$-0.63
$0$0$0$0$0$0
$0$0$0$0$0$3.19
$24.64$3.16$0$-3.43$2.24$25.41
$24.64$3.16$0$-3.43$2.24$28.60
$0.07$0.00$0.48$1.03$1.43$1.74
$22.33$1.98$-1.08$-15.27$-69.58$28.67
$-2.56$-2.13$31.51$-1.01$13.35$-1.59
$0$0$0$0$0$0
$-2.56$-2.13$31.51$-1.01$13.35$-1.59
$0.43$0.21$0.59$0.05$73.98$74.01
$0.43$0.21$0.59$0.05$73.98$74.01
$0$0$0$0$0$0
$0$0$-0.37$-0.39$-0.23$-0.12
$-2.13$-1.93$31.73$-1.34$87.10$72.30
$-14.74$-20.58$-39.09$-75.50$56.64$62.53
$4.61$4.48$3.10$2.83$4.29$3.20
$0$0$0$0$0$0